A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
about
Maintenance treatment of adolescent bipolar disorder: open study of the effectiveness and tolerability of quetiapineAtypical antipsychotics in bipolar disorder: systematic review of randomised trialsEffects of asenapine on depressive symptoms in patients with bipolar I disorder experiencing acute manic or mixed episodes: a post hoc analysis of two 3-week clinical trialsA critical appraisal of treatments for bipolar disorderA randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionPublication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorderQuetiapine monotherapy for bipolar depressionThe role of lamotrigine in the management of bipolar disorderCombination quetiapine therapy in the long-term treatment of patients with bipolar I disorder.Lurasidone for the treatment of bipolar depression: an evidence-based reviewReview of evidence for use of antidepressants in bipolar depressionGuideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012Review of pharmacological treatment in mood disorders and future directions for drug development.Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studiesThe International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise AlgorithmDo Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating OverviewEmerging targets for antidepressant therapiesExtended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled studyTreating insomnia improves mood state, sleep, and functioning in bipolar disorder: a pilot randomized controlled trialNovel targets for antidepressant therapiesCombined treatment with quetiapine and sertindole in therapy refractory insomnia after clozapine discontinuation.The study protocol of the Norwegian randomized controlled trial of electroconvulsive therapy in treatment resistant depression in bipolar disorder.Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSPQuetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies.Bipolar disorder.Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data.Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysisPossible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholismEffects of quetiapine and olanzapine in patients with psychosis and violent behavior: a pilot randomized, open-label, comparative studyA neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy.Role of extended release quetiapine in the management of bipolar disorders.Quetiapine for acute bipolar depression: a systematic review and meta-analysisPPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression.Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trialEfficacy and safety of extended-release quetiapine fumarate in youth with bipolar depression: an 8 week, double-blind, placebo-controlled trial.Atypical antipsychotic-induced mania/hypomania: a review of recent case reports and clinical studies.Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in patients with generalised anxiety disorder: an analysis of pooled data from three 8-week placebo-controlled studies.Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression.Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis.A review of bipolar disorder in adults.
P2860
Q21260254-B2F76B53-4820-4CE1-AD2A-7A22F8F114CAQ21260276-614485D0-3DFD-4B87-BF8E-2935C312B32BQ21260328-C03A018E-0FDC-4D62-B2F0-1AA21CE3052FQ24613657-30E346A0-F2A8-4C8C-9E25-96BBF76A7E31Q24630153-3BAA0E4B-D60C-4D43-9FBA-4957101FB10DQ24643545-3EF72BC2-7609-496F-967E-F7A2F06BC963Q24644541-F5C1287A-FC02-4CF9-AB71-FDC7C980968DQ24658110-82B82475-EEF3-4570-BDA1-B5077CE3DDBDQ24814468-3053B7C5-05A4-4CA4-BD44-1CCC9E63DC04Q26796437-70A4E893-7E05-477D-9AE3-9A68ADC7A42CQ26824365-D62738E9-EC5C-4D3C-9ADF-3678DA57CEDBQ26824955-8FC28FBE-01B2-420F-8B1F-9FBDE300F8A7Q26853509-7B9C5B62-F4EC-4A69-BF1F-A4CA1026F08FQ27499305-3B6C4E33-70E6-4CFD-8D39-49018ECA9119Q28066714-CA221A0D-14CB-4B6D-AFA3-59DCCC3B3CB4Q28077687-FDA42148-8D73-4CC8-9B3F-AD09FD5ABF2FQ28247614-052FC1A2-6ABE-4E8E-BF96-34F714A15ECFQ28254377-E51903D1-475C-4D3D-A651-4AC26C5C1390Q28646967-568DDA65-A0A6-4EC1-9D94-FEFFCD7BD576Q28648254-3BE9F86B-3C87-41AD-8391-4CCA0C38E1DDQ30318839-A7AFB84E-F3B8-4C3D-83E7-C7341C0DE521Q30493934-A8976B6B-77A9-40FF-835C-C3DC8481C948Q30569917-BF9C5B48-6DFC-444D-B761-9310C98C2BA7Q31127921-F36D2EB8-EAF9-4297-B6BF-92B4472DD212Q33448290-1C1BB4E2-8916-49F0-8CD3-B87F6343B9ACQ33488312-E75C3416-9D72-4C48-B3A2-1D66C67F2FD6Q33529314-3DF00B01-B66D-46F8-8FA3-BE5DF2B55D65Q33548809-9E4A68FC-A81F-4AED-87C7-27D1263558E6Q33604943-8843947C-E4FD-4823-9EBF-E461ED5646E7Q33658525-F2C28FEB-3FDF-4B4B-8D89-61900D61B5D8Q33755661-24B748AC-B01A-43ED-B5C7-1DAFE0249D91Q33829611-F8BFD586-C9E7-4276-90DE-62976E1A6258Q33960389-E16F4232-1F4C-4EF9-903F-FD94ECD585F9Q34007868-8794CA14-128F-42A4-AB18-9AECD61D13DFQ34063590-1D01AEB0-C1EB-4B86-89AD-79777E3215EFQ34084811-D4E11CBA-C0CE-4079-8623-F5D0F81DC110Q34092254-A3C86AAD-F60C-4CED-B3EA-8B71723907F9Q34122966-4E4BA64F-A0DC-44EE-8E11-43556A711BE0Q34218568-FACC1CD4-C9BD-4062-830B-95804AE44FE5Q34237178-6968CD1F-464C-43B7-8C1F-2F7C74BBCF7A
P2860
A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
A randomized, double-blind, pl ...... of bipolar I or II depression.
@en
A randomized, double-blind, pl ...... of bipolar I or II depression.
@nl
type
label
A randomized, double-blind, pl ...... of bipolar I or II depression.
@en
A randomized, double-blind, pl ...... of bipolar I or II depression.
@nl
prefLabel
A randomized, double-blind, pl ...... of bipolar I or II depression.
@en
A randomized, double-blind, pl ...... of bipolar I or II depression.
@nl
P2093
P1476
A randomized, double-blind, pl ...... of bipolar I or II depression.
@en
P2093
Andrew J Cutler
Ellis Wilson
Jamie Mullen
Joseph R Calabrese
Margaret Minkwitz
Paul E Keck
Richard H Weisler
Robin McCoy
Wayne Macfadden
P304
P356
10.1176/APPI.AJP.162.7.1351
P407
P577
2005-07-01T00:00:00Z